ClinicalTrials.Veeva

Menu

Canthaxanthin Retinopathy: A Long-term Observation

U

University of Cologne

Status

Completed

Conditions

Canthaxanthin Retinopathy

Study type

Observational

Funder types

Other

Identifiers

NCT01128062
AHARMS-8310

Details and patient eligibility

About

Canthaxanthine is a naturally occurring carotenoid that has been a popular over-the-counter oral artificial tanning agent in Europe, Canada, and Australia since 1979. It is also used at low dosage as a food-colouring agent and as a therapeutic agent for photosensitivity disorders such as erythropoietic protoporphyria. Canthaxanthin retinopathy was first described in 1982 by Cortin et al. In Germany the office of the federal board of health refused the permit for oral tanning agents containing canthaxanthine in 1985. At that time the long-term course of the disease was not known. 25 years later the investigators did these long-term follow-up examinations.

Enrollment

35 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients using oral tanning agents for at least 2 months.
  • patients of 18 years or older

Exclusion criteria

  • none.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems